Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation

The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of vascular and endovascular surgery 2021-02, Vol.61 (2), p.201-209
Hauptverfasser: Fabre, Dominique, Mougin, Justine, Mitilian, Delphine, Cochennec, Frederic, Garcia Alonso, Carlos, Becquemin, Jean-Pierre, Desgranges, Pascal, Allaire, Eric, Hamdi, Sarah, Brenot, Philippe, Bourkaib, Riyad, Haulon, Stephan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 2
container_start_page 201
container_title European journal of vascular and endovascular surgery
container_volume 61
creator Fabre, Dominique
Mougin, Justine
Mitilian, Delphine
Cochennec, Frederic
Garcia Alonso, Carlos
Becquemin, Jean-Pierre
Desgranges, Pascal
Allaire, Eric
Hamdi, Sarah
Brenot, Philippe
Bourkaib, Riyad
Haulon, Stephan
description The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patients with AAA at high risk of type II endoleak (EL with EVAR with ASCE during the period 2014–2019. Patients at high risk of type II EL were randomised to standard EVAR (group A) or EVAR with coil ASCE (group B). The primary endpoint was the rate of all types of EL during follow up. Secondary endpoints included freedom from type II EL related re-interventions, and aneurysm sac diameter and volume variation at two year follow up. Adverse events included type II EL and re-interventions. CTA and Duplex ultrasound scans were scheduled at 30 days, six months, one year, and two years after surgery. Ninety-four patients were enrolled, 47 in each group. There were no intra-operative complications. At M1, 16/47 early type II EL occurred (34%) in group A vs. 2/47 (4.3%) in group B (p 
doi_str_mv 10.1016/j.ejvs.2020.11.028
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04534954v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1078588420310492</els_id><sourcerecordid>2471539379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-761f3a1d7a402b565e969afb63db8ea8c694fa0586b892fc8817c902c22156093</originalsourceid><addsrcrecordid>eNp9kU1v1DAYhC0EoqXwBzggH6lEFn_HkbhEq4UirQQqizhajvNG9SqJFzsJ6oH_jsOWHjm91nhmDvMg9JqSDSVUvT9u4LikDSMsC3RDmH6CLqnkrGBUyaf5TUpdSK3FBXqR0pEQIimXz9EF51wwJfUl-v01hnQCN_kF3uFbO7Zh8AlafPgV8BbGKQI-RG97HDq8y7-LTW7ubcS3cLI-rnLdrKExe-oQJ-9wPcIc79OAf_jpDof494Z5wt-sw7uhCb1PdvJhfImedbZP8OrhXqHvH3eH7U2x__Lp87beF05wMRWloh23tC2tIKyRSkKlKts1ireNBqudqkRnidSq0RXrnNa0dBVhjjEqFan4Fbo-997Z3pyiH2y8N8F6c1PvzaoRIbmopFho9r49e08x_JwhTSYP4qDv7QhhToaJMm9c8XKtZWeryyOmCN1jNyVmRWSOZkVkVkSGUpMR5dCbh_65GaB9jPxjkg0fzgbIiyweoknOw-ig9TGDMm3w_-v_A8CRoiI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2471539379</pqid></control><display><type>article</type><title>Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Fabre, Dominique ; Mougin, Justine ; Mitilian, Delphine ; Cochennec, Frederic ; Garcia Alonso, Carlos ; Becquemin, Jean-Pierre ; Desgranges, Pascal ; Allaire, Eric ; Hamdi, Sarah ; Brenot, Philippe ; Bourkaib, Riyad ; Haulon, Stephan</creator><creatorcontrib>Fabre, Dominique ; Mougin, Justine ; Mitilian, Delphine ; Cochennec, Frederic ; Garcia Alonso, Carlos ; Becquemin, Jean-Pierre ; Desgranges, Pascal ; Allaire, Eric ; Hamdi, Sarah ; Brenot, Philippe ; Bourkaib, Riyad ; Haulon, Stephan</creatorcontrib><description>The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patients with AAA at high risk of type II endoleak (EL with EVAR with ASCE during the period 2014–2019. Patients at high risk of type II EL were randomised to standard EVAR (group A) or EVAR with coil ASCE (group B). The primary endpoint was the rate of all types of EL during follow up. Secondary endpoints included freedom from type II EL related re-interventions, and aneurysm sac diameter and volume variation at two year follow up. Adverse events included type II EL and re-interventions. CTA and Duplex ultrasound scans were scheduled at 30 days, six months, one year, and two years after surgery. Ninety-four patients were enrolled, 47 in each group. There were no intra-operative complications. At M1, 16/47 early type II EL occurred (34%) in group A vs. 2/47 (4.3%) in group B (p &lt; .001). At M6, 15/36 type II EL (41.7%) occurred in group A vs. 2/39 (4.26%) in group B (p &lt; .001). At M12, 15/37 type II El (40.5%) occurred in group A vs. 5/35 (14.3%) in group B (p = .018). At 24 months, 8/32 type 2 El (25%) occurred in group A vs. 3/29 (6.5%) in group B (p = .19). Kaplan–Meier curves of survival free from EL and re-interventions were significantly in favour of group B (p &lt; .001). Aneurysm sac volume decreased significantly in group B compared with group A at M6 (p = .081), at M12 (p = .004), and M24 (p = .001). For selected patients at risk of EL, ASCE seems effective in preventing EL at one, six, and at 12 months. However, the difference was not statistically significant at 24 months. ASCE decreases the re-intervention rate two years after EVAR. A significantly faster aneurysm volume shrinkage was observed at one and two years following surgery. (SCOPE 1 trial: NCT01878240)</description><identifier>ISSN: 1078-5884</identifier><identifier>EISSN: 1532-2165</identifier><identifier>DOI: 10.1016/j.ejvs.2020.11.028</identifier><identifier>PMID: 33342658</identifier><language>eng</language><publisher>England: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Aneurysm ; Aortic Aneurysm, Abdominal - therapy ; Blood Vessel Prosthesis Implantation - methods ; Combined Modality Therapy ; Embolisation ; Embolization, Therapeutic - methods ; Endoleak ; Endovascular ; Endovascular Procedures - methods ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Life Sciences ; Male ; Middle Aged ; Prevention ; Proportional Hazards Models ; Prospective Studies ; Reoperation - statistics &amp; numerical data ; Treatment Outcome</subject><ispartof>European journal of vascular and endovascular surgery, 2021-02, Vol.61 (2), p.201-209</ispartof><rights>2020 European Society for Vascular Surgery</rights><rights>Copyright © 2020 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-761f3a1d7a402b565e969afb63db8ea8c694fa0586b892fc8817c902c22156093</citedby><cites>FETCH-LOGICAL-c434t-761f3a1d7a402b565e969afb63db8ea8c694fa0586b892fc8817c902c22156093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejvs.2020.11.028$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33342658$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04534954$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Fabre, Dominique</creatorcontrib><creatorcontrib>Mougin, Justine</creatorcontrib><creatorcontrib>Mitilian, Delphine</creatorcontrib><creatorcontrib>Cochennec, Frederic</creatorcontrib><creatorcontrib>Garcia Alonso, Carlos</creatorcontrib><creatorcontrib>Becquemin, Jean-Pierre</creatorcontrib><creatorcontrib>Desgranges, Pascal</creatorcontrib><creatorcontrib>Allaire, Eric</creatorcontrib><creatorcontrib>Hamdi, Sarah</creatorcontrib><creatorcontrib>Brenot, Philippe</creatorcontrib><creatorcontrib>Bourkaib, Riyad</creatorcontrib><creatorcontrib>Haulon, Stephan</creatorcontrib><title>Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation</title><title>European journal of vascular and endovascular surgery</title><addtitle>Eur J Vasc Endovasc Surg</addtitle><description>The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patients with AAA at high risk of type II endoleak (EL with EVAR with ASCE during the period 2014–2019. Patients at high risk of type II EL were randomised to standard EVAR (group A) or EVAR with coil ASCE (group B). The primary endpoint was the rate of all types of EL during follow up. Secondary endpoints included freedom from type II EL related re-interventions, and aneurysm sac diameter and volume variation at two year follow up. Adverse events included type II EL and re-interventions. CTA and Duplex ultrasound scans were scheduled at 30 days, six months, one year, and two years after surgery. Ninety-four patients were enrolled, 47 in each group. There were no intra-operative complications. At M1, 16/47 early type II EL occurred (34%) in group A vs. 2/47 (4.3%) in group B (p &lt; .001). At M6, 15/36 type II EL (41.7%) occurred in group A vs. 2/39 (4.26%) in group B (p &lt; .001). At M12, 15/37 type II El (40.5%) occurred in group A vs. 5/35 (14.3%) in group B (p = .018). At 24 months, 8/32 type 2 El (25%) occurred in group A vs. 3/29 (6.5%) in group B (p = .19). Kaplan–Meier curves of survival free from EL and re-interventions were significantly in favour of group B (p &lt; .001). Aneurysm sac volume decreased significantly in group B compared with group A at M6 (p = .081), at M12 (p = .004), and M24 (p = .001). For selected patients at risk of EL, ASCE seems effective in preventing EL at one, six, and at 12 months. However, the difference was not statistically significant at 24 months. ASCE decreases the re-intervention rate two years after EVAR. A significantly faster aneurysm volume shrinkage was observed at one and two years following surgery. (SCOPE 1 trial: NCT01878240)</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aneurysm</subject><subject>Aortic Aneurysm, Abdominal - therapy</subject><subject>Blood Vessel Prosthesis Implantation - methods</subject><subject>Combined Modality Therapy</subject><subject>Embolisation</subject><subject>Embolization, Therapeutic - methods</subject><subject>Endoleak</subject><subject>Endovascular</subject><subject>Endovascular Procedures - methods</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevention</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Reoperation - statistics &amp; numerical data</subject><subject>Treatment Outcome</subject><issn>1078-5884</issn><issn>1532-2165</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAYhC0EoqXwBzggH6lEFn_HkbhEq4UirQQqizhajvNG9SqJFzsJ6oH_jsOWHjm91nhmDvMg9JqSDSVUvT9u4LikDSMsC3RDmH6CLqnkrGBUyaf5TUpdSK3FBXqR0pEQIimXz9EF51wwJfUl-v01hnQCN_kF3uFbO7Zh8AlafPgV8BbGKQI-RG97HDq8y7-LTW7ubcS3cLI-rnLdrKExe-oQJ-9wPcIc79OAf_jpDof494Z5wt-sw7uhCb1PdvJhfImedbZP8OrhXqHvH3eH7U2x__Lp87beF05wMRWloh23tC2tIKyRSkKlKts1ireNBqudqkRnidSq0RXrnNa0dBVhjjEqFan4Fbo-997Z3pyiH2y8N8F6c1PvzaoRIbmopFho9r49e08x_JwhTSYP4qDv7QhhToaJMm9c8XKtZWeryyOmCN1jNyVmRWSOZkVkVkSGUpMR5dCbh_65GaB9jPxjkg0fzgbIiyweoknOw-ig9TGDMm3w_-v_A8CRoiI</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Fabre, Dominique</creator><creator>Mougin, Justine</creator><creator>Mitilian, Delphine</creator><creator>Cochennec, Frederic</creator><creator>Garcia Alonso, Carlos</creator><creator>Becquemin, Jean-Pierre</creator><creator>Desgranges, Pascal</creator><creator>Allaire, Eric</creator><creator>Hamdi, Sarah</creator><creator>Brenot, Philippe</creator><creator>Bourkaib, Riyad</creator><creator>Haulon, Stephan</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>202102</creationdate><title>Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation</title><author>Fabre, Dominique ; Mougin, Justine ; Mitilian, Delphine ; Cochennec, Frederic ; Garcia Alonso, Carlos ; Becquemin, Jean-Pierre ; Desgranges, Pascal ; Allaire, Eric ; Hamdi, Sarah ; Brenot, Philippe ; Bourkaib, Riyad ; Haulon, Stephan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-761f3a1d7a402b565e969afb63db8ea8c694fa0586b892fc8817c902c22156093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aneurysm</topic><topic>Aortic Aneurysm, Abdominal - therapy</topic><topic>Blood Vessel Prosthesis Implantation - methods</topic><topic>Combined Modality Therapy</topic><topic>Embolisation</topic><topic>Embolization, Therapeutic - methods</topic><topic>Endoleak</topic><topic>Endovascular</topic><topic>Endovascular Procedures - methods</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevention</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Reoperation - statistics &amp; numerical data</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fabre, Dominique</creatorcontrib><creatorcontrib>Mougin, Justine</creatorcontrib><creatorcontrib>Mitilian, Delphine</creatorcontrib><creatorcontrib>Cochennec, Frederic</creatorcontrib><creatorcontrib>Garcia Alonso, Carlos</creatorcontrib><creatorcontrib>Becquemin, Jean-Pierre</creatorcontrib><creatorcontrib>Desgranges, Pascal</creatorcontrib><creatorcontrib>Allaire, Eric</creatorcontrib><creatorcontrib>Hamdi, Sarah</creatorcontrib><creatorcontrib>Brenot, Philippe</creatorcontrib><creatorcontrib>Bourkaib, Riyad</creatorcontrib><creatorcontrib>Haulon, Stephan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>European journal of vascular and endovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fabre, Dominique</au><au>Mougin, Justine</au><au>Mitilian, Delphine</au><au>Cochennec, Frederic</au><au>Garcia Alonso, Carlos</au><au>Becquemin, Jean-Pierre</au><au>Desgranges, Pascal</au><au>Allaire, Eric</au><au>Hamdi, Sarah</au><au>Brenot, Philippe</au><au>Bourkaib, Riyad</au><au>Haulon, Stephan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation</atitle><jtitle>European journal of vascular and endovascular surgery</jtitle><addtitle>Eur J Vasc Endovasc Surg</addtitle><date>2021-02</date><risdate>2021</risdate><volume>61</volume><issue>2</issue><spage>201</spage><epage>209</epage><pages>201-209</pages><issn>1078-5884</issn><eissn>1532-2165</eissn><abstract>The benefit of aneurysm sac coil embolisation (ASCE) during endovascular aortic repair (EVAR) of abdominal aortic aneurysm (AAA) remains unclear. This prospective randomised two centre study (SCOPE 1: Sac COil embolisation for Prevention of Endoleak) compared the outcomes of standard EVAR in patients with AAA at high risk of type II endoleak (EL with EVAR with ASCE during the period 2014–2019. Patients at high risk of type II EL were randomised to standard EVAR (group A) or EVAR with coil ASCE (group B). The primary endpoint was the rate of all types of EL during follow up. Secondary endpoints included freedom from type II EL related re-interventions, and aneurysm sac diameter and volume variation at two year follow up. Adverse events included type II EL and re-interventions. CTA and Duplex ultrasound scans were scheduled at 30 days, six months, one year, and two years after surgery. Ninety-four patients were enrolled, 47 in each group. There were no intra-operative complications. At M1, 16/47 early type II EL occurred (34%) in group A vs. 2/47 (4.3%) in group B (p &lt; .001). At M6, 15/36 type II EL (41.7%) occurred in group A vs. 2/39 (4.26%) in group B (p &lt; .001). At M12, 15/37 type II El (40.5%) occurred in group A vs. 5/35 (14.3%) in group B (p = .018). At 24 months, 8/32 type 2 El (25%) occurred in group A vs. 3/29 (6.5%) in group B (p = .19). Kaplan–Meier curves of survival free from EL and re-interventions were significantly in favour of group B (p &lt; .001). Aneurysm sac volume decreased significantly in group B compared with group A at M6 (p = .081), at M12 (p = .004), and M24 (p = .001). For selected patients at risk of EL, ASCE seems effective in preventing EL at one, six, and at 12 months. However, the difference was not statistically significant at 24 months. ASCE decreases the re-intervention rate two years after EVAR. A significantly faster aneurysm volume shrinkage was observed at one and two years following surgery. (SCOPE 1 trial: NCT01878240)</abstract><cop>England</cop><pub>Elsevier B.V</pub><pmid>33342658</pmid><doi>10.1016/j.ejvs.2020.11.028</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1078-5884
ispartof European journal of vascular and endovascular surgery, 2021-02, Vol.61 (2), p.201-209
issn 1078-5884
1532-2165
language eng
recordid cdi_hal_primary_oai_HAL_hal_04534954v1
source MEDLINE; ScienceDirect Journals (5 years ago - present); EZB-FREE-00999 freely available EZB journals
subjects Adult
Aged
Aged, 80 and over
Aneurysm
Aortic Aneurysm, Abdominal - therapy
Blood Vessel Prosthesis Implantation - methods
Combined Modality Therapy
Embolisation
Embolization, Therapeutic - methods
Endoleak
Endovascular
Endovascular Procedures - methods
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Life Sciences
Male
Middle Aged
Prevention
Proportional Hazards Models
Prospective Studies
Reoperation - statistics & numerical data
Treatment Outcome
title Prospective, Randomised Two Centre Trial of Endovascular Repair of Abdominal Aortic Aneurysm With or Without Sac Embolisation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A28%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective,%20Randomised%20Two%20Centre%20Trial%20of%20Endovascular%20Repair%20of%20Abdominal%20Aortic%20Aneurysm%20With%20or%20Without%20Sac%20Embolisation&rft.jtitle=European%20journal%20of%20vascular%20and%20endovascular%20surgery&rft.au=Fabre,%20Dominique&rft.date=2021-02&rft.volume=61&rft.issue=2&rft.spage=201&rft.epage=209&rft.pages=201-209&rft.issn=1078-5884&rft.eissn=1532-2165&rft_id=info:doi/10.1016/j.ejvs.2020.11.028&rft_dat=%3Cproquest_hal_p%3E2471539379%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2471539379&rft_id=info:pmid/33342658&rft_els_id=S1078588420310492&rfr_iscdi=true